Salix Pharmaceuticals Ltd (SLXP)
Quote as of 4:00 PM ET 09/02/2010
| Exchange: |
NASDAQ GS |
| Last: |
39.63 |
| Change: |
$0.53 |
| Percent Change: |
1.36 |
| Volume: |
556,062 |
Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract. The Company?s products include XIFAXAN, MOVIPREP, OSMOPREP, VISICOL, APRISO, METOZOLV, AZASAN, ANUSOL-HC, PROCTOCORT cream, PEPCID, Oral Suspension DIURIL and COLAZAL. The Company?s products under development include Rifaximin, Crofelemer, Balsalazide disodium tablet and Budesonide foam.
|
|
|